About this trial
The statistical analysis of the collected data aims to reveal the many factors that influence patient involvement in clinical trials. Findings will be disseminated through conferences and scholarly papers to benefit all parties participating in clinical trials.
These findings will help to shape the design of future clinical trials for people with tardive dyskinesia, as well as enhance recruiting techniques and retention rates.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of tardive dyskinesia
Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
No prior treatment for tardive dyskinesia
Disqualifiers
Enrolled in another research study
Inability to provide written informed consent
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Trial population
Tardive dyskinesia patients who are actively considering enrolling in a clinical trial for the said condition, but have not yet completed enrollment and randomization phases.
Trial design
Case-crossover
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Rate of patients who decide to enroll in a tardive dyskinesia clinical research.
Number of tardive dyskinesia study participants who remain in clinical study until completion.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: